UnitedHealth Group Other Receivables increased by 14.6% to $32.76B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.3%, from $27.46B to $32.76B. Over 4 years (FY 2020 to FY 2024), Other Receivables shows an upward trend with a 20.1% CAGR.
Significant fluctuations may indicate one-time events or changes in non-operating business activities.
This category includes miscellaneous claims for cash that are not derived from standard trade sales of pharmaceutical pr...
Varies widely based on the complexity of a company's tax structure and collaborative R&D agreements.
other_receivables| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.63B | $14.08B | $13.87B | $11.99B | $12.44B | $13.68B | $12.77B | $14.70B | $16.13B | $17.75B | $17.69B | $19.28B | $26.76B | $27.46B | $26.09B | $26.02B | $28.58B | $32.76B |
| QoQ Change | — | +11.5% | -1.5% | -13.5% | +3.7% | +10.0% | -6.7% | +15.1% | +9.8% | +10.0% | -0.3% | +9.0% | +38.8% | +2.6% | -5.0% | -0.3% | +9.8% | +14.6% |
| YoY Change | — | — | — | — | -1.5% | -2.8% | -7.9% | +22.5% | +29.7% | +29.7% | +38.6% | +31.2% | +65.9% | +54.7% | +47.4% | +34.9% | +6.8% | +19.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.